| Literature DB >> 31303547 |
Jian Hui Low1, Pin Li1, Elaine Guo Yan Chew2, Bingrui Zhou1, Keiichiro Suzuki3, Tian Zhang4, Michelle Mulan Lian2, Meng Liu1, Emi Aizawa5, Concepcion Rodriguez Esteban6, Kylie Su Mei Yong7, Qingfeng Chen8, Josep M Campistol9, Mingliang Fang10, Chiea Chuen Khor11, Jia Nee Foo12, Juan Carlos Izpisua Belmonte13, Yun Xia14.
Abstract
Human pluripotent stem cell-derived kidney organoids recapitulate developmental processes and tissue architecture, but intrinsic limitations, such as lack of vasculature and functionality, have greatly hampered their application. Here we establish a versatile protocol for generating vascularized three-dimensional (3D) kidney organoids. We employ dynamic modulation of WNT signaling to control the relative proportion of proximal versus distal nephron segments, producing a correlative level of vascular endothelial growth factor A (VEGFA) to define a resident vascular network. Single-cell RNA sequencing identifies a subset of nephron progenitor cells as a potential source of renal vasculature. These kidney organoids undergo further structural and functional maturation upon implantation. Using this kidney organoid platform, we establish an in vitro model of autosomal recessive polycystic kidney disease (ARPKD), the cystic phenotype of which can be effectively prevented by gene correction or drug treatment. Our studies provide new avenues for studying human kidney development, modeling disease pathogenesis, and performing patient-specific drug validation.Entities:
Keywords: ARPKD; developmental modeling; disease modeling; implantation; kidney organoid; nephron patterning; patient-specific iPSC; pluripotent stem cells; single-cell RNA-seq; vascular progenitors
Year: 2019 PMID: 31303547 PMCID: PMC6731150 DOI: 10.1016/j.stem.2019.06.009
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633